Healthcare Hyperspectral Imaging Market: Global Drivers, Restraints, Opportunities, Trends, and Forecast: 2018–2024
Hyperspectral imaging (HSI) has a similar information collection process like other spectral imaging across the electromagnetic spectrum. The primary goal of hyperspectral imaging is to achieve the spectrum for every pixel in the image scene captures and identify the target with high precision and details. Hyperspectral imaging, also known as imaging spectrometry, provides high accuracy and detailed information. HSI has a wide range of applications in vegetation, archaeology, forensic, crime detection, food quality, diagnosis, and many more. The emerging application has led to an increase in the demand for HSI in non-invasive diagnosis, especially in surgical guidance.
Hyperspectral imaging assists in distinguishing spectrally unique materials and also helps to extract the detailed information that is not possible with other types of remotely sensed technique. It is a type of imaging with a large number of narrow wavebands, where each scene contains information about the radiation reflected/absorbed range of wavelength. This has become one of the key methods for evaluating any target in non-destructive and remote-based imaging.
The global healthcare hyperspectral imaging market has immense growth opportunities in both developed and developing regions. The manufacturers are focusing on developing healthcare hyperspectral imaging systems to support image analysis and fasten the process of various imaging facilities, especially during surgeries. There is increased adoption of imaging systems for high-quality imaging, screening, and diagnosing due to improved access and encouragement from the government & other healthcare institutions, especially in the US, Canada, France, Germany, and the UK.
Imaging mass spectrometry and functional magnetic resonance imaging are the forms of hyperspectral imaging with a wide range of applications in healthcare. The advancements in hyperspectral imaging systems have changed the way the diagnoses in healthcare are being done, and a significant change is witnessed in the optical imaging market.
A majority of the leading healthcare hyperspectral imaging companies focus on developing high-quality cameras that provide an assessment of diagnosis and treatment for various chronic diseases. The manufacturers are emerging with different strategies to compete in the market along with various brands, models, and designs.
The factors such as the rise in the aging population, increased incidence of chronic diseases, the introduction of portable/handheld hyperspectral imaging systems with high operability and safety, and an increase in the number of diagnostic procedures are expected to positively impact the growth of the healthcare hyperspectral imaging market, thereby leading to the high demand for advanced healthcare hyperspectral imaging devices.
Headwall Photonics, Specim Spectral Imaging, Norsk Elektro Optikk, IMEC, and Surface Optics have the maximum revenue generation in the global healthcare hyperspectral imaging market.
Market Analysis – The global healthcare hyperspectral imaging market is estimated to witness a CAGR of 14.4% during the forecast period 2018–2024. The market is analyzed based on four segments: product type, application type, end-users, and regions.
Regional Analysis – The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). In North America, the US and Canada are the leading countries owing to the highest number of diagnostic cases in 2017. This region dominates the overall presence of healthcare hyperspectral imaging and has the most diversified devices available in the market. It has the highest percentage of the elderly population with many individuals suffering from chronic diseases such as CVD, neurovascular disorders, orthopedic surgeries, and other urology-related disorders. This has helped most of the vendors to sustain and grow over the period and maintain their product presence in the market. Europe is the second leading region and held more than 30% of the market share in 2017. The market in Europe was largely driven by advancements in medical device technologies. The factors such as an increase in the prevalence of diseases, continuous adoption of advanced technologies, and increasing aging population are driving the market. The leading countries in Europe include Germany, France, the UK, and Italy.
Key Competitive Facts
• The market is highly competitive with all the players competing to dominate. Intense competition, rapid advancements in technology, and frequent changes in government policies are the key factors that confront the market.
• The manufacturers have formulated various strategies for developing innovative healthcare hyperspectral imaging devices in the market.
Benefits – The report provides complete details about the usage and adoption rate of healthcare hyperspectral imaging devices. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the medical devices segment in the upcoming years along with the details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.
Table of content Healthcare Hyperspectral Imaging - Done
TABLE 1 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET BY END-USERS 47
TABLE 2 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET REVENUE BY REGIONS FORECAST, 2018–2024 ($MILLION) 50
TABLE 3 HEADWALL PHOTONICS INC.: PRODUCT OFFERINGS 60
TABLE 4 HEADWALL PHOTONICS INC.: RECENT DEVELOPMENTS 60
TABLE 5 SPECIM SPECTRAL IMAGING LTD.: PRODUCT OFFERINGS 64
TABLE 6 SPECIM SPECTRAL IMAGING LTD.: RECENT DEVELOPMENTS 64
TABLE 7 NORSK ELEKTRO OPTIKK AS: OFFERINGS 68
TABLE 8 IMEC: OFFERINGS 70
TABLE 9 IMEC: RECENT DEVELOPMENTS 71
TABLE 10 SURFACE OPTICS CORP.: OFFERINGS 74
TABLE 11 SNAPSHOT OF TELOPS 77
TABLE 12 SNAPSHOT OF APPLIED SPECTRAL IMAGING 78
TABLE 13 SNAPSHOT OF CORNING INC. 79
CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 10
CHART 2 IMPERATIVES OF EMERGING MARKETS 18
CHART 3 PESTLE ANALYSIS OF HEALTHCARE HYPERSPECTRAL IMAGING MARKET 19
CHART 4 RESEARCH METHODOLOGY OF GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET 22
CHART 5 GLOBAL MEDICAL IMAGING MARKET, GEOGRAPHICAL SPLIT, 2017 24
CHART 6 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET REVENUE, 2017–2024 ($MILLION) 28
CHART 7 PORTER 5 FORCES ON HEALTHCARE HYPERSPECTRAL IMAGING MARKET 30
CHART 8 HEALTHCARE HYPERSPECTRAL IMAGING MARKET SEGMENTATION BY PRODUCTS 31
CHART 9 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET SHARE BY PRODUCTS, 2017 & 2024 (%) 31
CHART 10 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET OVERVIEW BY PRODUCTS, 2017 32
CHART 11 GLOBAL HYPERSPECTRAL CAMERAS MARKET REVENUE, 2017–2024 ($MILLION) 33
CHART 12 GLOBAL HYPERSPECTRAL COMPONENTS AND ACCESSORIES MARKET REVENUE, 2017–2024 ($MILLION) 34
CHART 13 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET REVENUE BY PRODUCTS, 2017–2024 ($MILLION) 34
CHART 14 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET SEGMENTATION, BY PRODUCT, 2017-2024 (%) 35
CHART 15 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET SEGMENTATION BY APPLICATION 35
CHART 16 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET SHARE BY APPLICATION, 2017 (%) 36
CHART 17 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES 37
CHART 18 DRO - IMPACT ANALYSIS OF HEALTHCARE HYPERSPECTRAL IMAGING MARKET 42
CHART 19 KEY STAKEHOLDERS 42
CHART 20 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET SHARE BY END-USER SEGMENTATION, 2017 (%) 45
CHART 21 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET SHARE BY GEOGRAPHICAL SEGMENTATION, 2017 AND 2024 (%) 49
CHART 22 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET OVERVIEW BY REGIONS, 2017 50
CHART 23 HEALTHCARE HYPERSPECTRAL IMAGING MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION) 51
CHART 24 HEALTHCARE HYPERSPECTRAL IMAGING MARKET REVENUE IN EUROPE, 2017–2024 ($MILLION) 53
CHART 25 HEALTHCARE HYPERSPECTRAL IMAGING MARKET REVENUE IN ASIA PACIFIC, 2017–2024 ($MILLION) 55
CHART 26 HEALTHCARE HYPERSPECTRAL IMAGING MARKET REVENUE IN REST OF THE WORLD, 2017–2024 ($MILLION) 56
CHART 27 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET SEGMENTATION BY GEOGRAPHY, 2017-2024 ($MILLION) 57
CHART 28 GLOBAL HEALTHCARE HYPERSPECTRAL IMAGING MARKET SEGMENTATION BY GEOGRAPHY, 2017-2024 (%) 57
CHART 29 HEADWALL PHOTONICS INC.: OVERVIEW SNAPSHOT 61
CHART 30 HEADWALL PHOTONICS INC.: APPLICATIONS 61
CHART 31 HEADWALL PHOTONICS INC.: SWOT ANALYSIS 62
CHART 32 SPECIM SPECTRAL IMAGING LTD.: OVERVIEW SNAPSHOT 65
CHART 33 SPECIM SPECTRAL IMAGING LTD.: APPLICATIONS 66
CHART 34 SPECIM SPECTRAL IMAGING LTD.: SWOT ANALYSIS 67
CHART 35 NORSK ELEKTRO OPTIKK AS: OVERVIEW SNAPSHOT 68
CHART 36 NORSK ELEKTRO OPTIKK AS: SWOT ANALYSIS 69
CHART 37 IMEC: OVERVIEW SNAPSHOT 71
CHART 38 IMEC: OFFERINGS 72
CHART 39 IMEC: SWOT ANALYSIS 73
CHART 40 SURFACE OPTICS CORP.: OVERVIEW SNAPSHOT 74
CHART 41 SURFACE OPTICS CORP.: SWOT ANALYSIS 75
Headwall Photonics, Specim Spectral Imaging, Norsk Elektro Optikk, IMEC, and Surface Optics